{"id":"W2598244667","doi":"10.1200/jco.2014.32.15_suppl.647","title":"Quality of life (QOL) among patients (pts) with HER2+ breast cancer (bc) treated with adjuvant lapatinib and/or trastuzumab in the ALTTO study (BIG 2-06, Alliance N063D).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Trastuzumab; Lapatinib; Breast cancer; Adjuvant; Oncology; Internal medicine; Quality of life (healthcare); Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000651083,0.0002531764,0.0004272696,0.0001432853,0.0002019395,0.0003999744,0.0001576455,0.0003433758,0.001376031],"category_scores_gemma":[0.0006907989,0.0001566637,0.0005892464,0.0003492664,0.0001862602,0.0003012338,0.0003150216,0.0006390431,0.0001474834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003551519,"about_ca_system_score_gemma":0.000243758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000851113,"about_ca_topic_score_gemma":0.001369841,"domain_scores_codex":[0.9997738,0.0001049389,0.00001588841,0.00003700613,0.00003034916,0.00003803683],"domain_scores_gemma":[0.9996483,0.00005190896,0.0001384057,0.00001238364,0.00001612601,0.000132919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1353862,0.007733809,0.7960104,0.0004691217,0.002408882,0.0002252679,0.0002413022,0.001283037,0.003521049,0.00009911082,0.003444942,0.0491768],"study_design_scores_gemma":[0.01517654,0.043569,0.9372002,0.00004242184,0.000775685,0.0002530332,0.0001129462,0.0009838234,0.0003651264,0.00009340591,0.001411172,0.00001662106],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998569,0.0006230461,0.00003764843,0.00009137482,0.00001241341,0.00004330193,0.0003391182,0.000002273283,0.00028184],"genre_scores_gemma":[0.9987675,0.0002572215,0.00005951004,0.0001066303,0.00002006573,0.00006522673,0.0005257954,5.280035e-7,0.0001975621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001376031,"threshold_uncertainty_score":0.004603267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2042912456911575,"score_gpt":0.5118660664074929,"score_spread":0.3075748207163354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}